Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity. - Wikidata - awgldk - TriplyDB

Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity.

Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity.

http://www.wikidata.org/entity/Q51939446

about

Chemotherapy-induced peripheral neurotoxicity: a critical analysis Vincristine-induced peripheral neuropathy in pediatric cancer patients Correction and transformation of normative neurophysiological data: is there added value in the diagnosis of distal symmetrical peripheral neuropathy?A framework for assessment in oncology rehabilitation.Optimizing measures of HIV-associated neuropathy Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients Longitudinal assessment of oxaliplatin-induced neuropathy.Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma.Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy.Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia.Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature.Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations.Chemotherapy-induced polyneuropathy: major agents and assessment by questionnaires.Assessment scales for the diagnosis of polyneuropathy.Chemotherapy-induced peripheral neuropathy: A current review.Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.Integrin beta-3 L33P: a new insight into the pathogenesis of chronic oxaliplatin-induced peripheral neuropathy?Pattern of peripheral nerve involvement in Machado-Joseph disease: neuronopathy or distal axonopathy? A clinical and neurophysiological evaluation.Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics.The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers.Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome.Serum methylmalonic acid correlates with neuropathic pain in idiopathic Parkinson's disease.Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy.Pain in Platin-Induced Neuropathies: A Systematic Review and Meta-Analysis.Brain connectivity abnormalities extend beyond the sensorimotor network in peripheral neuropathy.Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients.Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale.Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross-sectional study.In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials.Prospective study of peripheral neuropathy in Machado-Joseph disease Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol Chemotherapy-Induced Neuropathy

P2860

Q27010318-BE6DA410-6FAE-46A4-8B1B-1544C0A9DD20 Q28078232-3D891143-F659-42B7-820B-843BE3B64D0E Q34079067-39052A71-8E35-4C76-ADAA-FABF4660C050 Q34259686-2D37E06E-32B4-4B7D-8346-65ADA373670F Q34476396-93652912-1A6D-46F9-8FD9-7C8817F87102 Q34486506-31C593B9-7426-49CB-9D60-8EC8CB64D64B Q34562783-29919FB9-10FD-45FA-8D9F-0BEE96C78ED2 Q35210263-BD2D921C-1408-4561-B7FF-4B3C35FE0551 Q35584874-95D9DCD1-9D02-4033-9A43-3FCB37F18643 Q36037229-AE4D37D2-4F28-4106-8AFD-E347E03F53C7 Q37090630-86A818B8-2984-4BEC-AF31-8DC8A3B717E4 Q37398949-45DAE14D-59F2-48E1-BC9E-B5F2CD5E9B6B Q37632970-7C465D79-0021-412D-AC29-9F9FD350B6CD Q37659699-38E61DDD-EA6A-4BD0-8FBD-765C721A5407 Q37672348-736DED1F-DC7F-42B7-8E75-443303AB573F Q38209390-F8651F3B-DE70-4C96-BADA-E9597DC74565 Q38770566-654C3195-E845-4623-BDBE-9DF5361E2B17 Q39293928-0C9EC9BA-6EC6-45AE-9D7A-078A597C1C01 Q39356105-45B6B4B9-3E20-4257-80A0-E634BFEB455C Q40358186-C0546EA2-ACFE-4B3C-8D34-8AB786257265 Q43146147-A38F4212-279F-4D37-B383-988C9D4E5E23 Q43475319-C0CA9720-C55A-4D91-8422-0D4300D5DA66 Q44301929-40C64E0F-92BD-47F0-9C55-D6AB762FB31F Q45350320-46A2FFE4-D537-43BD-B994-AFA9DA3714DA Q46606896-9DF441F8-09AB-45ED-AE8F-F3643AE9DBC9 Q47423347-34EC0DC2-FC90-43B5-A9B0-DB350B55C218 Q47904919-0562C378-E123-4DFD-A355-5E48654E4A37 Q48020601-732FCF67-CDFF-4C48-8C3D-34F4EB7F7EA8 Q48192466-D282AA2C-1164-4D6A-8C06-E216F804E466 Q48321600-B21ECDB4-3B55-4CC9-B53E-8BB1D7DD7729 Q49169362-D40C0F90-E8EF-4C21-8868-9B926E8FDEFB Q50922149-6C2DEF42-3226-4A09-A253-09BDF7359D03 Q51000217-D09583AF-BDB4-455E-8FB0-E983DCE44A69 Q52838772-9CA394E8-C9E4-4388-98BD-7FDD922A39F8 Q55241487-7E174376-B5C3-4ED8-B988-D03E44B203D8 Q57086542-1BF7282D-56D2-47D8-A8A2-7121147810B0 Q57167257-BC008B81-C070-41E3-9F95-4D82B4F71E4F Q57212709-CBA4BD4D-3F06-4137-922F-575AFFCBB800 Q58874394-A89CC9E1-09F1-4676-B955-B293AEBF98C8

P2860

Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity.

http://www.wikidata.org/entity/Q51939446

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Multi-center assessment of the ...... uced peripheral neurotoxicity.

@en

Multi-center assessment of the ...... uced peripheral neurotoxicity.

@nl

type

label

Multi-center assessment of the ...... uced peripheral neurotoxicity.

@en

Multi-center assessment of the ...... uced peripheral neurotoxicity.

@nl

prefLabel

Multi-center assessment of the ...... uced peripheral neurotoxicity.

@en

Multi-center assessment of the ...... uced peripheral neurotoxicity.

@nl

P1433

Q51939446-1CC72C6C-A4F1-449B-914D-7E22A4DBFFC4

P1476

Q51939446-A3D068BC-EBB7-4DC4-8BF7-0F3C50F9B401

P2093

Q51939446-0252CDEF-5410-4885-A965-8FF5B69E51C9

Q51939446-0BE644F7-B5B6-4A83-B974-4424A0FBEDEA

Q51939446-95562131-44E6-498B-A06B-CBC6BC1806BC

Q51939446-A664B596-FB2E-4192-80BD-CEA0B31724CB

Q51939446-B4CFF5E5-4E17-4F0A-84A4-82E92D25D3D3

Q51939446-C77233A3-DCE5-4A87-AB55-9C25E9DF9275

Q51939446-DA20E95E-F463-4F70-95E0-A0B008154AA7

Q51939446-F29AD94E-66B8-47FA-8CA8-A65BF6B76F84

P2860

Q51939446-219D1C6A-F111-4DB2-BEF0-D717D11A1239

Q51939446-243FE0D3-94E9-4982-A570-6A9F769928D0

Q51939446-575C0F14-A476-4225-BB31-B83974A98FCE

Q51939446-97E32B54-6FD6-47AE-9148-9EF045999503

Q51939446-A35C8542-15AF-472C-BEAB-B572F96B840B

Q51939446-EB948FB7-2118-443E-8FB3-EBB422A44F9E

Q51939446-F5084812-C59B-4A66-B45B-C5992AE70166

P304

Q51939446-5FF21012-37E8-48C5-BB23-8264CDF81400

P31

Q51939446-7D83A183-0380-478B-9E43-A3A3140CCC4D

P356

Q51939446-3C288E11-1A3E-48C0-95F4-2D4785CB184C

P433

Q51939446-E08DB7D2-F8CC-4B7C-8964-A4EC36EE7041

P478

Q51939446-F8A28521-81B5-4B5D-B5B9-B1B1AACF5A93

P50

Q51939446-408B4B0B-8990-44BF-BAFC-4D6C9E49BD06

Q51939446-5C13CEF8-36AA-408E-98B9-2C577B0F493D

Q51939446-D55DAFCA-3B42-4FC0-980B-5370BDE2B375

Q51939446-FEC56C81-D151-4BE8-BDC6-9B8DDEE1C7DC

P577

Q51939446-B3805822-3535-47B4-8B6F-7F8DAA245017

P5875

Q51939446-D0D75DDC-2836-44F0-A505-CA7BCECF5098

P698

Q51939446-FD0823E2-2581-4C91-A6A1-1AB367A0F624

P921

Q51939446-1AFD9432-DECA-490A-B3CC-B2BC88950AF6

Q51939446-D1947E1C-BBC5-48F9-A31A-9C34D3AACA8F

P356

J.1085-9489.2006.00078.X

P1433

Journal of the Peripheral Nervous System

P1476

Multi-center assessment of the ...... duced peripheral neurotoxicity

@en

P2093

Chiara Briani

http://www.w3.org/2001/XMLSchema#string

Dario Cocito

http://www.w3.org/2001/XMLSchema#string

Elisabetta Ghiglione

http://www.w3.org/2001/XMLSchema#string

Giuditta Giussani

http://www.w3.org/2001/XMLSchema#string

Italian NETox Group

http://www.w3.org/2001/XMLSchema#string

Mariagrazia Manicone

http://www.w3.org/2001/XMLSchema#string

Rosaria Plasmati

http://www.w3.org/2001/XMLSchema#string

Stefano Jann

http://www.w3.org/2001/XMLSchema#string

P2860

Grading of chemotherapy-induced peripheral neuropathy.

Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.

Thalidomide-induced neuropathy.

Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale.

Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study.

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy.

A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.

P304

135-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1085-9489.2006.00078.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Gabriele Siciliano

Guido Cavaletti

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6995742

http://www.w3.org/2001/XMLSchema#string

P698

16787511

http://www.w3.org/2001/XMLSchema#string

P921